Journal of the American Society of Echocardiography
Volume 22, Issue 12 , Pages 1335-1337 , December 2009

Diastolic Dysfunction and Histopathology in Hypertrophic Cardiomyopathy: Is Relaxation in Disarray?

  • Harry Rakowski, MD, FASE

      Affiliations

    • Division of Cardiology, University Health Network, Toronto General Hospital, Toronto, Canada
    • Division of Cardiology, Rambam Health Care Center, Haifa, Israel
    • ,
  • Shemy Carasso, MD

      Affiliations

    • Division of Cardiology, University Health Network, Toronto General Hospital, Toronto, Canada
    • Division of Cardiology, Rambam Health Care Center, Haifa, Israel

References 

  1. Soor GS, Luk A, Ahn E, Abraham JR, Woo A, Ralph-Edwards A, et al. Hypertrophic cardiomyopathy: current understanding and treatment objectives. J Clin Pathol. 2009;62:226–235
  2. Schoen F. The heart. In:  Kumar V,  Abbas AK,  Fausto N editor. Robbins and Cotran. Pathologic basis of disease. Philadelphia, PA: Elsevier; 2005;p. 555–618
  3. Maron BJ, Anan TJ, Roberts WC. Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation. 1981;63:887–890
  4. Davies MJ, McKenna WJ. Hypertrophic cardiomyopathy-pathology and pathogenesis. Histopathology. 1995;26:493–500
  5. Carasso S, Rakowski R. Hypertrophic Cardiomyopathy. In:  Klein AL,  Garcia MJ editor. Diastology, clinical approach to diastolic heart failure. PA: Saunders-Elsevier; 2008;p. 287–300
  6. Notomi Y, Popovic ZB, Yamada H, Wallick DW, Martin MG, Oryszak SJ, et al. Ventricular untwisting: a temporal link between left ventricular relaxation and suction. Am J Physiol Heart Circ Physiol. 2008;294:H505–H513
  7. Carasso S, Yang H, Woo A, Vannan MA, Jamorski M, Wigle ED, et al. Systolic myocardial mechanics in hypertrophic cardiomyopathy: novel concepts and implications for clinical status. J Am Soc Echocardiogr. 2008;21:75–83
  8. Menon SC, Eidem BW, Dearani JA, Ommen SR, Ackerman MJ, Miller D. Diastolic dysfunction and its histopathological correlation in obstructive hypertrophic cardiomyopathy in children and adults. J Am Soc Echocardiogr. 2009;22:1327-34
  9. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 1997;30:1527–1533
  10. Nagueh SF, Lakkis NM, Middleton KJ, Spencer WH, Zoghbi WA, Quinoñes MA. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation. 1999;99:254–261
  11. Nishimura R, Appleton C, Redfield M, Ilstrup D, Holmes D, Tajik A. Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol. 1996;28:1226–1233
  12. Geske JB, Sorajja P, Nishimura RA, Ommen SR. Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation. 2007;116:2702–2708
  13. Severino S, Caso P, Galderisi M, De Simone L, Petrocelli A, de Divitiis O, et al. Use of pulsed Doppler tissue imaging to assess regional left ventricular diastolic dysfunction in hypertrophic cardiomyopathy. Am J Cardiol. 1998;82:1394–1398
  14. Pirat B, Khoury DS, Hartley CJ, Tiller L, Rao L, Schulz DG, et al. A novel feature-tracking echocardiographic method for the quantitation of regional myocardial function: validation in an animal model of ischemia-reperfusion. J Am Coll Cardiol. 2008;51:651–659
  15. Sachdev V, Shizukuda Y, Brenneman CL, Birdsall CW, Waclawiw MA, Arai AE, et al. Left atrial volumetric remodeling is predictive of functional capacity in nonobstructive hypertrophic cardiomyopathy. Am Heart J. 2005;149:730–736
  16. Yang H, Woo A, Monakier D, Jamorski M, Fedwick K, Wigle ED, et al. Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. J Am Soc Echocardiogr. 2005;18:1074–1082
  17. Colan SD, Lipshultz SE, Lowe AM, Sleeper LA, Messere J, Cox GF, et al. Epidemiology and cause specific outcome of hypertrophic cardiomyopathy in children. Circulation. 2007;115:773–781
  18. Blauwet LA, Ackerman MJ, Edwards WD, Riehle DL, Ommen SR. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: Correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin system. Cardiovasc Pathol. 2009;18:262–268
  19. Carasso S, Rakowski H. Myocardial fibrosis and regional function in hypertrophic cardiomyopathy: may the force be with you. J Am Soc Echocardiogr. 2008;21:1306–1308
  20. Varnava AM, Elliott PM, Mahon N, Davies MJ, McKenna WJ. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol. 2001;88:275–279

 There are no conflicts of interest to disclose.

PII: S0894-7317(09)00951-1

doi: 10.1016/j.echo.2009.10.006

Journal of the American Society of Echocardiography
Volume 22, Issue 12 , Pages 1335-1337 , December 2009

Article Tools

* Image Usage & Resolution